Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics | $25.66 | -$8.44 | -24.75% | 4.9M | $3.1B | $12.91$42.13 |
| ELAB | Pmgc | $4.27 | -$1.00 | -18.94% | 270K | $2.7M | $3.54$398.86 |
| BIYA | Baiya International Group | $3.98 | -$0.63 | -13.67% | 21.2K | $5.5M | $3.65$200.00 |
| AHT | Ashford Hospitality Trust | $3.74 | -$0.58 | -13.43% | 40.6K | $28M | $2.90$10.35 |
| ATRA | Atara Biotherapeutics | $5.14 | -$0.74 | -12.60% | 629.4K | $42M | $5.01$19.15 |
| INV | Innventure | $3.82 | -$0.53 | -12.10% | 1.2M | $294M | $2.36$13.05 |
| RGC | Regencell Bioscience | $38.91 | -$5.20 | -11.79% | 278K | $22B | $0.09$83.60 |
| MNTS | Momentus | $9.15 | -$1.20 | -11.56% | 501K | $14M | $4.73$160.65 |
| ESPR | Esperion Therapeutics | $3.18 | -$0.37 | -10.42% | 2.8M | $849M | $0.69$4.18 |
| PDDL | GraniteShares ETF Trust - GraniteShares 2x Long Pdd Daily ETF | $27.78 | -$2.94 | -9.57% | 21.8K | - | $24.19$43.73 |
Related Articles
Featured Article
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
Cory Renauer|Jul 21, 2024
The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.
Down 57%, Is AbCellera Biologics a Buy on the Dip?
Cory Renauer|Jun 13, 2024
Wall Street analysts say this drug developer can more than double your money.
Advertisement
3 Growth Stocks That Could Go Parabolic in 2024
George Budwell, PhD|Jan 15, 2024
These innovation-oriented companies could take flight this year.
1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy
Keith Speights|Apr 13, 2023
These companies are leading the way in using AI in healthcare.
Could an FDA Approval Send This Stock Flying?
David Jagielski, CPA|Mar 1, 2023
Is now the time to load up on this struggling stock?
2 Real Estate Stocks to Avoid Like the Plague
Liz Brumer|Feb 18, 2022
These two stocks are headed in the wrong direction, and the risks far outweigh any potential reward.
Here's What Investors Need to Know About Sight Sciences Stock
Rachel Warren and Asit Sharma, CPA|Jan 12, 2022
The company is a newer player in the medical devices space.
Should Investors Consider Sight Sciences Stock?
Rachel Warren, Jason Hall, and Asit Sharma, CPA|Jan 10, 2022
The company recently became publicly traded.
2 Massive Catalysts Sinking Crypto Mining Stocks Right Now
Chris MacDonald and Eric Bleeker|Dec 30, 2021
Crypto miners haven't been feeling the love from investors lately -- here's why.
